While the effects of CDK9 inhibition can be manifold and not solely due to decreased MCL‐1 levels [29, 40], the breadth of expression and demonstration that direct MCL‐1 inhibition with A‐1210477 phenocopies the CDK9 inhibition implicates the former as a relevant target in MCL. Here, CDK9 is linked to mantle cell lymphoma.